A molecular analysis of the low serum deoxyribonuclease activity in lupus patients
- 12 October 2001
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (10) , 2446-2447
- https://doi.org/10.1002/1529-0131(200110)44:10<2446::aid-art409>3.0.co;2-u
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Features of systemic lupus erythematosus in Dnase1-deficient miceNature Genetics, 2000
- The molecular basis for genetic polymorphism of human deoxyribonuclease II (DNase II): a single nucleotide substitution in the promoter region of human DNase II changes the promoter activityFEBS Letters, 2000
- A New Allele, DNASE1*6, of Human Deoxyribonuclease I Polymorphism Encodes an Arg to Cys Substitution Responsible for Its InstabilityBiochemical and Biophysical Research Communications, 1999
- Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythematosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assayClinical and Experimental Immunology, 1997
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosusRheumatology International, 1981
- A radial diffusion assay for plasma and serum deoxyribonuclease IRheumatology International, 1981
- Actin Is the Naturally Occurring Inhibitor of Deoxyribonuclease IProceedings of the National Academy of Sciences, 1974